Stock TPIA MYCOTOPIA THERAPIES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Mycotopia Therapies, Inc.

Equities

TPIA

US62846W1071

Market Closed - OTC Markets
Other stock markets
 02:04:51 2024-04-18 pm EDT 		5-day change 1st Jan Change
0.0719 USD -5.57% Intraday chart for Mycotopia Therapies, Inc. -27.96% +349.38%
2023 Mycotopia Therapies, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
2023 Mycotopia Therapies, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Mycotopia Therapies Acquires AI Robotics Assets with a Total Transaction Value of $9 Million
AQ
Mycotopia Therapies, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Mycotopia Therapies, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Mycotopia Therapies, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Mycotopia Therapies : Non-Reliance on Previously Issued Financial Report - Form 8-K
PU
MYCOTOPIA THERAPIES, INC. : Non-Reliance on Previous Financials, Audits or Interim Review (form 8-K)
AQ
MYCOTOPIA THERAPIES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION (form 10-K)
AQ
Mycotopia Therapies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Mycotopia Therapies, Inc. Auditor Raises 'Going Concern' Doubt
CI
MYCOTOPIA THERAPIES, INC. : Termination of a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
PSLY.com, Inc. Ei.Ventures, Inc. and Mycotopia Therapies Inc. Terminate Agreement and Plan of Merger
AQ
Ei.Ventures, Inc. cancelled the acquisition of Mycotopia Therapies Inc. from EHAVE, Inc. (OTCPK:EHVV.F) and others in a reverse merger transaction.
CI
Ehave Shareholder from CEO Ben Kaplan and Corporate Update
AQ
MYCOTOPIA THERAPIES, INC. MANAGEMENT'S DISCUSSION AND ANLAYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
Mycotopia Therapies, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
MYCOTOPIA THERAPIES, INC. MANAGEMENT'S DISCUSSION AND ANLAYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
Mycotopia Therapies, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
MYCOTOPIA THERAPIES, INC. MANAGEMENT'S DISCUSSION AND ANLAYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
Mycotopia Therapies, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
Ehave Announces Mycotopia Therapies Reaches Definitive Agreement on Triangular Merger with Ei.Ventures to Form PSLY.com to List on NASDAQ
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TPIA Stock
  4. News Mycotopia Therapies, Inc.